Evidence map›Paper›PMID 39233894›Full record

ReviewDigital health

Global bibliometric mapping of the research trends in artificial intelligence-based digital pathology for lung cancer over the past two decades.

Dan-Dan Xiong, Rong-Quan He, Zhi-Guang Huang, Kun-Jun Wu, Ying-Yu Mo, Yue Liang, Da-Ping Yang, Ying-Hui Wu, Zhong-Qing Tang, Zu-Tuan Liao and 1 more

Abstract readReview
In one paragraph

Review in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Dan-Dan XiongDepartment of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Rong-Quan HeDepartment of Medical Oncology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Zhi-Guang HuangDepartment of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Kun-Jun WuDepartment of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Ying-Yu MoDepartment of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
Yue LiangDepartment of Pathology, Liuzhou People's Hospital, Liuzhou, Guangxi, China.
Da-Ping YangDepartment of Pathology, Guigang City People's Hospital, Guigang, Guangxi, China.
Ying-Hui WuDepartment of Pathology, The First People's Hospital of Yulin, Yulin, Guangxi, China.
Zhong-Qing TangDepartment of Pathology, Gongren Hospital of Wuzhou, Wuzhou, Guangxi, China.
Zu-Tuan LiaoDepartment of Pathology, The First People's Hospital of Hechi, Hechi, Guangxi, China.
Gang ChenDepartment of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.ORCID https://orcid.org/0000-0002-4864-1451

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objective: The rapid development of computer technology has led to a revolutionary transformation in artificial intelligence (AI)-assisted healthcare. The integration of whole-slide imaging technology with AI algorithms has facilitated the development of digital pathology for lung cancer (LC). However, there is a lack of comprehensive scientometric analysis in this field. Methods: A bibliometric analysis was conducted on 197 publications related to digital pathology in LC from 502 institutions across 39 countries, published in 97 academic journals in the Web of Science Core Collection between 2004 and 2023. Results: Our analysis has identified the United States and China as the primary research nations in the field of digital pathology in LC. However, it is important to note that the current research primarily consists of independent studies among countries, emphasizing the necessity of strengthening academic collaboration and data sharing between nations. The current focus and challenge of research related to digital pathology in LC lie in enhancing the accuracy of classification and prediction through improved deep learning algorithms. The integration of multi-omics studies presents a promising future research direction. Additionally, researchers are increasingly exploring the application of digital pathology in immunotherapy for LC patients. Conclusions: In conclusion, this study provides a comprehensive knowledge framework for digital pathology in LC, highlighting research trends, hotspots, and gaps in this field. It also provides a theoretical basis for the application of AI in clinical decision-making for LC patients.

Indexed as

artificial intelligencebibliometricsdigital pathologyLung cancer

Identifiers

PMID39233894
PMCPMC11372859

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.